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Background: Asthma has been linked with prolonged time to pregnancy compared to
healthy controls, also asthma has been linked to a higher need for fertility treatment.
However, knowledge of the possible association between allergy and need for fertility
treatment is limited. Our aim was to explore a possible difference in having had fertility
treatment in women with asthma and live births in those with perennial allergy (animals,
fungi and dust mites) compared to no allergy/seasonal allergy. The primary outcome of
interest was fertility treatment.
Patients and Methods: Women enrolled in the Management of Asthma during Pregnancy
(MAP) program at Hvidovre Hospital, DK, were included in the present analysis provided
they fulfilled the following criteria: 1) diagnosed with asthma and current anti-asthma
therapy and 2) first visit to the respiratory outpatient clinic within the first 18 weeks of
pregnancy. Participants were divided into two groups: asthma with perennial allergy (cases)
and asthma with seasonal/no allergy (controls). Logistic regression analysis was applied, and
findings expressed as odds ratios (OR).
Results: Among women with asthma and perennial allergy (n=544 cases), 13.8% (n=75) had
fertility treatment, compared to only 10.1% (n=39) among women with asthma and seasonal/
no allergy (n=388, controls) (OR 1.43, 95% CI 0.95–2.16, p=0.087). This association
remained statistically insignificant after adjusting for confounders, including BMI (OR
1.19, 95% CI 0.77–1.84, p=0.433). In women ≥35 years of age, 28% (n=44) and 20%
(n=19), respectively, among cases and controls had fertility treatment (OR 1.60, 95% CI
0.87–2.94, p=0.132), and likewise, statistically insignificant after adjusting for confounders
(OR 1.41, 95% CI 0.74–2.69, p<0.293).
Conclusion: In women with asthma and live births, our study revealed a trend towards an
association between perennial allergy and a higher need for fertility treatment compared to
seasonal/no allergy.
Keywords: asthma, allergy, pregnancy, IVF, ART, fertility, atopy
Background
In the western world, both asthma and infertility are among the most common chronic
conditions among women of reproductive age.1 Asthma is estimated to affect 8–12%
of the young population, whereas infertility is estimated to affect about 10% of the
young population.2,3
Recent studies have reported impaired fertility in couples where the women suffer
from asthma.4,5 A register study by Gade et al6 showed a prolonged time to pregnancy
(TTP) and a tendency towards an increased number of miscarriages among women
with asthma, particularly among those with severe asthma and above 30 years of age.
This is further supported by Hansen et al5 who reported a higher need for fertility
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treatment among women with asthma compared to women
without asthma. Whether well-controlled asthma improves
fertility is not entirely clear, Källen et al7 found an
increased incidence of infertility (involuntary childlessness)
among women prescribed anti-asthma drugs. However,
Grzeskowiak et al showed that women with asthma treated
with only rescue asthma medication had reduced fertility
compared to those treated with asthma controller medication
(15% lower (0.85 (95% CI 0.75–0.96))).8 The available
evidence, therefore, suggests that poorly controlled asthma
may have a negative impact on fertility. Furthermore, a lower
number of children among allergic women have been found
by Karmaus and Botezan.9 However, Gade et al found no
significant association between allergy, defined as a positive
skin prick test, and changes in time to pregnancy.6 They
found that women with only allergy had comparable time
to pregnancy as the general population.6 While women with
both asthma and allergy experienced prolonged TTP, which
was comparable to having asthma alone.6 The data on asthma
combined with allergy are contradictive; however, most
recent data points towards an association between reduced
fertility and female asthma.
Most available studies have primarily compared ferti-
lity in women with asthma and healthy controls. So far
little evidence has been published comparing different sub-
groups of women with asthma, in regard to fertility.
Our aim was to explore a possible difference in having
had fertility treatment in women with asthma and live
births in those with perennial allergy (animals, fungi and
dust mites) compared to no allergy/seasonal allergy. The
primary outcome was fertility treatment.
Patients and Methods
Materials
Management of Asthma during Pregnancy (MAP) program
was initiated in 2007, it is a prospective cohort study with
pregnant women which consecutively have been recruited
through the Department of Gynecology and Obstetrics,
Hvidovre Hospital, Denmark. If pregnant and referred to
Hvidovre Hospital (HvH) (approximately 7.000 per year,
corresponding to 10% of infants born in Denmark) the
women received a welcome letter from the Department of
Gynecology and Obstetrics informing the women about the
study and an invitation to participate in the MAP-program.
The acceptance to participate was done by e-mail (astmaog-
graviditet@regionh.dk). If the women accepted the invita-
tion, they were given a scheduled appointment (by letter) at
the out-patient clinic in the Respiratory department. All
participating women with asthma were included within the
first 18 weeks of their pregnancy, and were followed-up
assessment of asthma control, including spirometry and
exhaled nitric oxide, approximately every 4 weeks through-
out pregnancy.
Data come from the same cohort reported in 2019
comparing the entire asthma cohort to non-asthmatic con-
trols in regards to the need for fertility treatment.5
Methods
Information on fertility treatment (2007 to 2013) was
obtained from the Danish National Assisted Reproductive
Technology (ART) registry and the Medical Birth Registry.
The Danish ART registry includes all ART treatment-cycles
performed in public and private fertility clinics in Denmark
since 1994, with intrauterine insemination (IUI) cycles
added in 2006. Reporting to the ART registry is mandatory
for both public and private clinics. A unique personal iden-
tification number enables identification of all treatment
cycles received by each individual woman, and thereby
mapping of the complete fertility treatment history.
Women identified in the Danish ART registry were cross-
linked with the Danish Medical Birth registry to identify all
live births from the same woman.
Outcome
The variables that were analyzed were fertility treatment-
related live births and births after spontaneous conception
in women with perennial allergy (animals, fungi and dust
mites) compared to women with asthma and seasonal
allergy or no allergy.
Fractional Exhaled Nitric Oxide (FeNO)
The measurement of FeNO was done by using the chemilu-
minescence-analyzer (NIOX; Aerocrine, Solna, Sweden),
according to the ATS-guidelines.10 By using a biofeedback
monitor, patients exhaled from total lung capacity to resi-
dual volume at an expiratory flow rate of 50 mL/s. FeNO was
determined as the average of two measurements of the
plateau of the FeNO curve.
Spirometry
Spirometry was performed using the Easy One Ultrasonic
spirometer (NDD; Zurich, Switzerland), according to the
American Thoracic Society (ATS)/European Respiratory
Society recommendation,11 and predicted values for FEV1
and FVC were calculated according to reference equations.12
Tidemandsen et al Dovepress
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FEV1% ≥80% of the predicted value and a FEV1/FVC-ratio,
value of >0.7, were considered within the normal range. .
Allergy
Allergy status was based on the previous testing for atopy,
that is skin prick testing13 and/or measuring blood levels of
specific IgE to common aeroallergens and evaluated accord-
ing to international guidelines, together with patient-reported
allergic symptoms, including, eg, symptoms of rhino-
conjunctivitis and asthma, triggered by relevant exposure,
as evaluated at the first visit to the respiratory outpatient
clinic by one specialist in respiratory medicine (CSU).
The Cohort was divided into two main groups, perennial
allergy (ie, cases) and seasonal/no allergy (ie controls), and
subsequently further divided into three subgroups: “peren-
nial allergy” (animals, fungi and dust mite), “seasonal
allergy” (airborne allergens, eg, pollen, that appear only
during certain times of the year) and “no allergy”. Patients
with both perennial and seasonal allergy were allocated to
the perennial allergy group.
Statistical Analysis
The Data were analyzed by using IBM SPSS Statistics ver-
sion 22.0. Utilizing the two-tailed Student’s t-test we ana-
lyzed continuous and primarily descriptive variables. Binary
outcomes of interest were analyzed using the chi-square test.
To estimate the odds ratio (OR) we used logistic regression
analysis with 95% confidence intervals (CI) for the associa-
tion between allergic appearance (ie, cases vs controls) and
fertility treatment. The OR was adjusted for the following
potential confounding variables: body mass index (BMI),
smoking status, maternal age at time of giving birth, primi-
parity, being single and in a same-sex partnership, allergy
treatment and asthma severity (defined according to GINA-
guidelines14). A p-value <0.05 was considered significant.
We chose to include the following variables in our
model: body mass index (BMI), as high BMI has been
shown to influence fertility negatively,15 maternal age as
increasing age lowers the female fertility,16 smoking status
as smoking decreases fertility,17 being single and in a same-
sex partnership,18 allergy treatment19 into our model.
Results
Baseline Characteristics
A total of 872 women with asthma, contributing to 932
pregnancies, were included in the present analysis. The
cohort was divided into two main groups: Those with
perennial allergy (n=544) and those with seasonal/no allergy
(n=388). Women with perennial allergy (cases) were older
and more often non-smokers compared to the control group,
see Table 1 for detailed numbers. Subsequently, those with
seasonal/no allergy was further subdivided into seasonal
(n=210) vs no allergy (n=178).
Asthma Characteristics
No significant differences were found between cases and
controls regarding lung function (FEV1 < 80% vs FEV1 >
80%; p=0.237), FENO (low/high) (FENO ≤ 50 ppb vs
FENO > 50 ppb; p=0.360) or prescribed treatment with
inhaled corticosteroids (ICS) (yes/no) (p=0.168) among
women who conceived naturally and in those conceiving
after fertility treatment.
Baseline characteristics, including use of asthma med-
ication and lung function, of the cohort are presented in
Table 2.
Fertility Treatment Among Cases and
Controls
The prevalence of fertility treatment ahead of live births
was 13.8% (n=75) among women with asthma and peren-
nial allergy compared to 10.1% (n= 39) in the control group
(OR 1.43, 95% CI 0.95–2.16, p<0.087). After adjusting for
BMI, status, primiparity, age, being single, smoking, in
same-sex relationship, asthma severity, and allergy treat-
ment (oral antihistamine, eye drops and nasal steroids) the
association remained statistically non-significant (OR 1.19,
95% CI 0.77–1.84, p = 0.433). Repeating the analysis with
women only contributing to their first pregnancy did not
change the overall observations (n=872).
When looking at the different types of fertility treat-
ment (IUI and ART, there was no significant difference
between groups in regard to IUI treatment (OR 1.23, 95%
CI 0.67–2.27, p=0.510) and Assisted Reproductive
Technology (ART= IVF and ICSI) treatment (OR 1.54,
95% CI 0.91–2.60, p = 0.109), also after adjusting for
confounders (Table 3).
Fertility Treatment Stratified by Age
Among Women with Asthma and
Perennial Allergy vs Women with Asthma
and Seasonal/No Allergy
After stratifying cases and controls into two age-groups, ie,
of women <35 years and women ≥35 years, we re-analyzed
fertility treatment and no significant association was found
Dovepress Tidemandsen et al
Journal of Asthma and Allergy 2020:13 submit your manuscript | www.dovepress.com
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between women with asthma and perennial allergy and
women with asthma and seasonal/no allergy in regard to
fertility treatment. In women ≥35 years, it was 28% (n=44)
and 20% (n=19) of cases and controls, respectively (OR
1.60, 95% CI 0.87–2.94, p=0.132)
Causes of Infertility in Women Who
Received Fertility Treatment, Cases vs
Controls
When exploring causes of infertility in the two groups
there was no significant difference, ie, male factor, female
factor, combined or idiopathic, between the women with
asthma and perennial allergy and women with asthma and
seasonal/no allergy. The causes of infertility were equally
distributed within each group (Table 4). Likewise, no
difference was found between the groups in type of ferti-
lity treatment.
Discussion
In this study, our findings did not reach statistical signifi-
cance; however, one could argue we found a trend towards
that more women with perennial allergy conceived after
fertility treatment compared to women with either seasonal
allergy or no allergy.
As shown in the study by Gade et al6 and Hansen et al5
when stratifying for age (aged 35 years or older), the
association between asthma and need for fertility treatment
was stronger compared to the general population. In our
study of allergic asthma patients, we found no statistical
difference between the two asthma groups when dividing
Table 1 Demographic Characteristics of the Study Population Comprising 932 Individuals Divided in Different Groups After Allergy
Status
Characteristics Cohort Cases (Asthma +
Perennial Allergy)
Asthma +
Season Allergy
Asthma +
No Allergy
Controls (Asthma and
Season + No Allergy)
p-value (Cases
vs Controls)
Subjects (n) 932 544 210 178 388
Age (years) 31.4 (±4.7) 31.4 (±4.7) 30.9 (±4.5) 30.8 (±5) 30.7 (±4.8) 0.029
BMI (kg/cm2) 24.1 (±4.6) 24 (±4.5) 23.6 (±3.9) 25 (±5.6) 24.2 (±5.5) 0.395
Current smokers 39 (4.2) 15 (2.8) 3 (1.7) 19 (10.7) 24 (6.2) 0.010
Ex-smokers 215 (23) 130 (23.9) 34 (18.9) 51 (24.5) 85 (21.9) 0.477
Never smokers 678 (72.7) 399 (73.3) 143 (79.4) 136 (65.4) 279 (71.9) 0.627
Mild asthma 661 (71) 392 (72.1) 142 (78.9) 102 (57.3) 269 (69.3) 0.366
Moderate/severe asthma 271 (29) 152 (27.9) 38 (21.1) 76 (42.7) 119 (30.7) 0.366
Primiparity 626 (67.2) 371 (68.2) 111 (61.7) 116 (65.2) 255 (65.7) 0.427
Notes: Data are given as mean with SD in brackets or numbers with percentages in brackets. Bold values indicate significant p-values <0.05.
Table 2 Characteristics of the Lung Function and Asthma Therapy in the Cohort at First Visit in the Management of Asthma During
Pregnancy Program
Characteristics Cohort Cases (Asthma +
Perennial Allergy)
Controls (Asthma +
Season and No Allergy)
p-value
Subjects (n) 932 544 388
FeNO > 50 ppb 43 (4.6) 28 (5.1) 15 (3.9) 0.360
Lung Function
FEV1 < 80% pred. 150 (16.1) 81 (14.9) 69 (17.8) 0.237
FEV1/FVC < 0.7 46 (4.9) 27 (5.0) 19 (4.9) 0.963
Asthma Therapy
Inhaled corticosteroids (ICS) 598 (64.2) 359 (66.0) 239 (61.6) 0.168
Low dose* 438 (47) 268 (49.3) 170 (43.8) 0.100
Medium dose* 153 (16.4) 90 (16.3) 63 (16.2) 0.901
High dose* 7 (0.8) 5 (0.9) 2 (0.5) 0.488
Long-acting beta-2 agonist in combination with ICS 17 (1.8) 12 (2.2) 5 (1.3) 0.308
Leukotriene receptor antagonist 8 (0.9) 4 (0.7) 4 (1.0) 0.631
Oral corticosteroids 1 (0.1) 0 1 (0.3) 0.994
Notes: Data are given as numbers with percentages in brackets. *Beclometasone equivalent doses.
Tidemandsen et al Dovepress
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the cohort in <35 years and women ≥35 years. Our contra-
dictive results could be explained by a possible under-
powered study.
In the study conducted by Tata et al,20 there was no
association between allergic disease and need for fertility
treatment. However, they showed an increased fertility within
the younger participants with allergic diseases compared to
women without allergic diseases. In our study, we found
a trend towards an increased association between asthma
with perennial allergy and infertility compared to only asthma
and infertility. The explanation for this finding could be that
perennial due to its daily symptoms and thereby chronic
feature has a greater effect on both the lungs and systemically.
This assumption is based on a review of available studies,
Ulrik21 that describes that loss of lung function was higher in
patients with daily symptoms compared to those having sea-
sonally asthma. Leading to the assumption that perennial
asthma was more severe than seasonal asthma. Furthermore,
earlier findings have indicated that years exposed to low-grade
systemic inflammation in women with asthma may have an
influence on fertility,22–24 in our study we found no difference
within the groups as regards to age, a possibility could be that
an allergic component does not influence fertility more over
time. After adjusting for basic and lifestyle-related factors
there was still no significant difference.
However, a trend towards more women receiving ART
among the cases compared to the controls (8.5% vs 5.7%
p=0.109) was found. This could point towards a more diffi-
cult treatable infertility due to a higher level of atopic disease.
Strengths and Limitations
A strength of the study is that it was conducted at
a hospital with a large number of deliveries covering
10% of all births every year in Denmark and that the
hospital covers a population with a wide range of socio-
economical classes. Because of national data on fertility
treatment, we have complete coverage of those who
received fertility treatment. The risk of selection bias is
very low due to this national register design. Most impor-
tant, the same physician validated all the cases who were
diagnosed with asthma and allergy therefore the validity of
the diagnoses is very high.
One limitation of the study is that only women with
asthma and live births were included. Thus, women with
asthma who received fertility treatment without conceiving
were not included, which is a potential bias, but unfortu-
nately, we do not have access to these data.
Another important bias is a possible underpowered
study, as the result shows a trend of an association
between perennial allergy and increased need for fertility
Table 3 Mode of Conception and Specified Fertility Treatment in Women with Asthma in Regards to Allergy with Live Births
Characteristics Cases (Asthma +
Perennial Allergy)
Controls (Asthma +
Season and No Allergy)
Asthma +
Season
Allergy
Asthma +
No Allergy
OR (95% CI)
(Cases vs
Controls)
p-value
Subjects (n) 544 388 210 178
Mode of Conception
Fertility treatment 75 (13.8%) 39 (10.1%) 16 (8.9%) 23 (11.1%) OR 1.43 (0.95–2.16) =0.087
Adjusteda OR 1.17 (0.74–1.87) =0.502
Specified Fertility Treatment
Intrauterine insemination 29 (5.3%) 17 (4.4%) 11 (6.1%) 6 (2.9%) OR 1.23 (0.67–2.27) =0.510
Assisted reproductive technologyb 46 (8.5%) 22 (5.7%) 5 (2.8%) 17 (8.2%) OR 1.54 (0.91–2.60) =0.109
Spontaneous conception 469 (86%) 349 (90%) 164 (91.1%) 185 (88.9%) OR 0.70 (0.46–1.05) =0.087
Notes: aAdjusted for body mass index (BMI), smoking status, maternal age, primiparity, being in a same-sex relationship, being single and allergy treatment (eye drops,
antihistamine and nasal steroids). bAssisted reproductive technology: in vitro fertilization, intracytoplasmic sperm injection, frozen embryo transfer, aspiration of sperm,
unspecified.
Table 4 Characteristics of the Reasons for Fertility Treatment
Within Those Who Received Fertility Treatment, Management of
Asthma During Pregnancy Program
Characteristics Cohort Cases
(Asthma +
Perennial
Allergy)
Controls
(Asthma +
Season and
No Allergy)
p-value
Subjects (n) 114 75 39
Male factor 36 (31.6) 22 (29.3) 14 (35.9) 0.475
Female factor 37 (32.5) 24 (32) 13 (33.3) 0.885
Combined male
and female factor
3 (2.6) 3 (4) 0 (0) 0.998
Idiopathic factor 38 (33.3) 26 (34.7) 12 (30.8) 0.676
Note: Data are given as numbers with percentages in brackets.
Dovepress Tidemandsen et al
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treatment, but the results are not significant. After
a thorough review of the power calculation, the cohort
should be almost double in size, to be able to detect
a significant difference. Finally, on the basis of the pre-
valence of asthma in Denmark,25 out of all the women
with asthma giving birth each year at Hvidovre Hospital,
approximately two-third are enrolled in the MAP program.
It is of course a possibility that the last third of the women
with asthma who do not choose to be enrolled in the MAP
program is different from the two-thirds that do. Several
studies have shown that people who voluntarily participate
in studies are more resourceful and socio-economically
strong women.26–29 In our cohort, all participants have
voluntarily participated; therefore, it should not be
a difference related to this in the present study.
Interpretation in the Context of Other
Studies
Publication on the effect of allergies on fertility is limited.
There are studies published addressing allergy and preg-
nancy. It has been proposed that mast cell products such as
histamine and prostaglandins can cause contractions in the
uterus tissue. The uterus lining is in abundance of mast
cells. The myometrium fibers produce muscle contractions
when exposed to the right allergen.30 It is possible this also
holds true at conception, as the embryo need to attach to
the endometrium in the uterus.
Another possibility could be that the immune system
acts in an autoimmune way. The immune system reacts to
the embryo being implanted in the uterus lining, a reaction
to the embryo antigen. It has earlier been made a convincing
connection between autoimmune diseases and adverse
pregnancy outcome.31 A study in 2010 found a connection
between drug allergy, need for fertility treatment and
adverse pregnancy outcomes.32
It has been hypothesized that the underlying reason for
asthma affecting fertility negatively is the increased
inflammatory level in the body is increased. Growth fac-
tors have been shown to be involved in the inflammatory
response of asthma33 and are also known to play an
important role in the process of implantation of the
embryo.34 Balance between Th1 and Th2 responses in
the adaptive immune system has been considered impor-
tant. As the allergic response also is Th2 driven it is not
unlikely this is a contributing factor to asthma affecting
fertility. This mismatch in Th1 and Th2 response may be
of importance.34 Following these hypotheses, it seems
likely that allergy in combination with asthma can affect
fertility, but we are still in need of a better understanding
of the actions, interactions and immunological functions.
As far as asthma severity or asthma therapy and the
need for fertility treatment, we found no association.
Conclusion
A trend towards an association between perennial allergy
and asthma and the need for fertility treatment compared
to seasonal/no allergy, possibly statistically insignificant
due to the relatively small sample size. The trend towards
an association between female asthma with perennial
allergy and a reduction in fertility needs to be further
explored, preferably with a larger sample size.
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